drugset / Trial / NCT02297217
Chemoradiotherapy for Advanced Esophageal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study aims to show that the addition of carboplatin and paclitaxel chemotherapy to a palliative course of external beam radiation treatment improves both dysphagia relief and patient quality of life in patients with unresectable esophageal cancer.
Timeline
- Start
- 2019-11-21
- Primary completion
- 2027-04-30
- Completion
- 2028-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | Paclitaxel | Small molecule | 50 mg/m2 | Intravenous |